“Decreased BDNF Levels in Amygdala and Hippocampus After Intracerebroventricular Administration of Ouabain”. Archives of Clinical Psychiatry, vol. 39, no. 5, Jan. 2012, pp. 157-60, https://doi.org/10.1590/S0101-60832012000500002.